Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney risk
Fields of Study & Subjects
Diabetes Treatment and Management
Telemedicine and Telehealth Implementation
Diabetes Management and Research
Publication details
- Journal / source
- American Heart Journal
- Volume
- 296
- Pages
- 107359–107359
- Publication date
- 27 January 2026
- Language
- EN